Evidence map›Paper›PMID 37122328›Full record

ArticleFrontiers in medicine2023

Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.

Theodoros Karampitsakos, Vasilina Sotiropoulou, Matthaios Katsaras, Panagiota Tsiri, Vasiliki E Georgakopoulou, Ilias C Papanikolaou, Eleni Bibaki, Ioannis Tomos, Irini Lambiri, Ourania Papaioannou and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Theodoros Karampitsakos *Department of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Vasilina Sotiropoulou *Department of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Matthaios KatsarasDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Panagiota TsiriDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Vasiliki E GeorgakopoulouDepartment of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, Athens, Greece.
Ilias C PapanikolaouDepartment of Respiratory Medicine, Corfu General Hospital, Corfu, Greece.
Eleni BibakiLaboratory of Molecular and Cellular Pneumonology, Department of Thoracic Medicine, Medical School, University of Crete, Heraklion, Greece.
Ioannis Tomos5th Department of Respiratory Medicine, Hospital for Thoracic Diseases, 'SOTIRIA', Athens, Greece.
Irini LambiriLaboratory of Molecular and Cellular Pneumonology, Department of Thoracic Medicine, Medical School, University of Crete, Heraklion, Greece.
Ourania PapaioannouDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Eirini ZarkadiDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Emmanouil AntonakisDepartment of Respiratory Medicine, Corfu General Hospital, Corfu, Greece.
Aggeliki PandiDepartment of Respiratory Medicine, Corfu General Hospital, Corfu, Greece.
Elli MalakounidouDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Fotios SampsonasDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.
Sotiria MakrodimitriDepartment of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, Athens, Greece.
Serafeim Chrysikos5th Department of Respiratory Medicine, Hospital for Thoracic Diseases, 'SOTIRIA', Athens, Greece.
Georgios Hillas5th Department of Respiratory Medicine, Hospital for Thoracic Diseases, 'SOTIRIA', Athens, Greece.
Katerina Dimakou5th Department of Respiratory Medicine, Hospital for Thoracic Diseases, 'SOTIRIA', Athens, Greece.
Nikolaos TzanakisLaboratory of Molecular and Cellular Pneumonology, Department of Thoracic Medicine, Medical School, University of Crete, Heraklion, Greece.
Nikolaos V SipsasDepartment of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, Athens, Greece.
Katerina AntoniouLaboratory of Molecular and Cellular Pneumonology, Department of Thoracic Medicine, Medical School, University of Crete, Heraklion, Greece.
Argyris TzouvelekisDepartment of Respiratory Medicine, University General Hospital of Patras, Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.1083264.].

Indexed as

antifibroticsinterstitial lung diseaselong COVIDmachine learningpost-COVID-19

Identifiers

PMID37122328
PMCPMC10134070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.